CX Interviews
CX 2024: Get a ringside seat for the big BASIL-3 data reveal
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results [...]
CX 2023: Reaching a Multidisciplinary Consensus
 In conversation with CX Chairman Professor Roger Greenhalgh, aortic expert Alexander Zimmerman (Zurich, Switzerland) discusses the upcoming Aortic course (Wednesday, 26 April), the importance of continuous education for the practicing surgeon and, a multidisciplinary approach to treating and managing the [...]
CX 2023: Innovation and Audience Interaction
Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience. Register now to attend CX 2023! [...]
CX 2023: Challenging the Vascular Status Quo
 In this conversation between CX chairman Roger Greenhalgh and Professor of Vascular Surgery, Maarit Venermo (Helsinki, Finland), we discuss the importance of challenging the status quo in vascular and endovascular surgery. Professor Venermo [...]
CX 2023: Aortic Techniques & Technologies Highlights
Start planning your CX 2023 itinerary today! We sat down with CX Executive Board member, Tilo Kölbel (Hamburg, Germany), to discuss the upcoming presentations in the Aortic techniques & technologies sessions. Register for the CX 2023 Consensus [...]
CX 2023: Andrew Bradbury discusses BASIL-2 trial
"I am really looking forward to seeing everyone at CX 2023 and it is going to be a great meeting. It is a pleasure and a privilege for us to be [...]